255
Participants
Start Date
June 27, 2012
Primary Completion Date
January 3, 2017
Study Completion Date
March 4, 2019
PF-04449913
PF-04449913 administered orally and continuously for 28-days.
Low dose ARA-C (LDAC)
Low dose ARA-C (LDAC) administered at 20 mg SQ, BID on Days 1 through 10.
PF-04449913
PF-04449913 administered orally and continuously for 28 days.
Decitabine
Decitabine given at 20 mg/m2 over 1 hour infusion for 5-days
PF-04449913
PF-04449913 administered orally and continuously for 28 days
Daunorubicin
Daunorubicin given using 60 mg/m2 for 3-days
Cytarabine
Cytarabine 100 mg/m2 on days 1 through 7
PF-04449913
PF-04449913 administered orally and continuously for 28 days
Daunorubicin
Daunorubicin given using 60 mg/m2 for 3-days
Cytarabine
Cytarabine 100 mg/m2 on days 1 through 7
PF-04449913
PF-04449913 administered orally and continuously for 28 days (if randomized to receive PF-04449913)
Low dose ARA-C (LDAC)
Low dose ARA-C (LDAC) administered at 20 mg SQ, BID on Days 1 through 10.
A.O. Citta della Salute e della Scienza di Torino - S.C. Ematologia, Torino
Charite -Universitatsmedizin Berlin - Campus Benjamin Franklin, Berlin
Charite - Universitatsmedizin Berlin, Berlin
Roswell Park Cancer Institute, Buffalo
ASST Grande Ospedale Metropolitano Niguarda, Milan
Universitaetsklinikum Hamburg-Eppendorf, Hamburg
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Universitaetsklinikum Schleswig-Holstein, Kiel
Hospital Ramon y Cajal, Madrid
Emory University Hospital, Atlanta
Investigational Drug Service, Emory University Clinic, Atlanta
The Emory Clinic, Atlanta
Winship Cancer Institute, Emory University, Atlanta
Medizinische Hochschule Hannover, Hanover
Azienda Sanitaria Universitaria Integrata di Udine, Udine
H.Lee Moffitt Cancer Center and Research Institute, Tampa
University of Alabama at Birmingham, Birmingham
University of Alabama at Birmingham, Birmingham
Centennial Medical Center, Nashville
Sarah Cannon Research Institute, Nashville
Tennessee Oncology, PLLC, Nashville
Universitaetsklinikum Magdeburg A.oe.R., Magdeburg
Policlinico S. Orsola-Malpighi, Bologna
Hospital Universitario Virgen del Rocio, Seville
Cleveland Clinic Cancer Institute, Cleveland
Hospital Universitario y Politecnico La Fe, Valencia
University of Michigan Health System, Ann Arbor
Universitaetsklinikum Muenster, Münster
Johannes Gutenberg-Universitaet Mainz, Mainz
Johann Wolfgang Goethe University, Frankfurt am Main
Northwestern Medical Faculty Foundation, Chicago
Northwestern Medicine Developmental Therapeutics Institute, Chicago
Northwestern Memorial Hospital, Chicago
The University of Chicago Medical Center, Chicago
The University of Chicago's Medical Center, Chicago
Barnes Jewish Hospital North Campus, St Louis
Barnes-Jewish Hospital, St Louis
Washington University School of Medicine - Division of Bone Marrow Transplant & Leukemia, St Louis
Washington University School of Medicine, Siteman Cancer Center, St Louis
Siteman Cancer Center - West County, Creve Coeur
University of Kansas Hospital, Kansas City
University of Kansas Clinical Research Center, Fairway
University of Kansas Cancer Center and Medical Pavilion, Westwood
The University of Texas, MD Anderson Cancer Center, Houston
University of Colorado Denver, Aurora
University of Colorado Hospital, Aurora
Universitaetsklinikum Ulm, Ulm
Universitaetsklinikum Ulm, Ulm
Keck Hospital of USC, Los Angeles
LAC & USC Medical Center, Los Angeles
USC/Norris Comprehensive Cancer Center / Investigational Drug Services, Los Angeles
USC/Norris Comprehensive Cancer Center, Los Angeles
Ronald Reagan UCLA Medical Center Drug Information Center, Los Angeles
Ronald Reagan UCLA Medical Center, Los Angeles
UCLA Drug lnformation/lnvestigational Drugs, Los Angeles
UCLA Hematology/Oncology Clinic, Los Angeles
UC San Diego Medical Center - La Jolla, La Jolla
UC San Diego Medical Center - Hillcrest, San Diego
University of Washington-Seattle Cancer Care Alliance, Seattle
University of Washington Medical Center, Seattle
University of Alabama at Birmingham, Birmingham
UC San Diego Moores Cancer Center - Investigational Drug Services, La Jolla
UC San Diego Moores Cancer Center, La Jolla
Tufts Medical Center, Boston
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Dana Farber Cancer Institute (DFCI), Boston
University of Michigan Comprehensive Cancer Center Clinical Trials Office, Ann Arbor
Hackensack University Medical Center, Hackensack
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Juravinski Cancer Centre @ Hamilton Health Sciences, Hamilton
Centre de Sante et de Services Sociaux (CSSS) Champlain - Charles-Le Moyne, Greenfield Park
"Policlinico Universitario Umberto I Universita degli Studi La Sapienza Sezione di Ematologia", Rome
Uniwersyteckie Centrum Kliniczne Gdanskiego Uniwersytetu Medycznego, Gdansk
Oddzial Hematologii Z pododzialem chemioterapii-Klinika Hematologii Wojewodzkie Wielospecjalistyczne, Lodz
Dolnoslaskie Centrum Transplantacji Komorkowych z Krajowym Bankiem Dawcow Szpiku, Wroclaw
Hospital Universitario Germans Trias i Pujol, Badalona
Hospital del Mar, Barcelona
Hospital de la Santa Creu i Sant Pau, Barcelona
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Clinic de Barcelona, Barcelona
Lead Sponsor
Pfizer
INDUSTRY